Video analytics market was valued at $14.7 billion in 2025 and is projected to reach $56.3 billion by 2035, growing at a CAGR of 14.5% during the forecast Period (2026-2035). Rising investments in smart city projects and IoT-enabled infrastructure are fueling market growth through increased demand for automated traffic management, crowd monitoring, and urban safety solutions. For instance, in May 2025, Unleash Live, an AI?driven video analytics platform, secured $17?million in a Series?B funding round to support its international growth and product development initiatives. The Sydney?based company offers a cloud-connected platform that leverages artificial intelligence to analyze video from existing CCTV systems, drones, and other devices, enhancing workplace productivity and safety. It also features a marketplace of AI applications catering to diverse use cases, including traffic management and infrastructure monitoring. The funding will further strengthen enterprise and government solutions across energy, transport, utilities, and public safety sectors.

Composite windows and doors market is valued at $1.3 billion in 2025 and is projected to reach approximately $2.3 billion by 2035, expanding at a CAGR of 6.3% (2026–2035). The growth trajectory of the market is primarily driven by rising construction activities, increasing demand for energy-efficient building materials, and rapid urbanization across emerging economies. One of the key macro drivers influencing the market is the global construction industry expansion, particularly in residential and commercial infrastructure. According to the International Energy Agency (IEA), buildings and construction accounted for nearly 37% of global energy-related CO? emissions, which is accelerating the demand for energy-efficient materials such as composite doors and windows. These products offer superior insulation, durability, and low maintenance compared to traditional materials, making them a preferred choice in green building initiatives.

Fast food industry market was valued at approximately $825.0 billion in 2025 and is expected to reach around $1,403.8 billion by 2035, growing at a CAGR of 5.5% during the forecast period (2026–2035). Fast food includes a wide range of quick-service offerings such as burgers & sandwiches, pizza & pasta, chicken-based products, Asian quick-service cuisine, Mexican wraps, snacks & sides, and beverages, delivered through dine-in, takeaway, drive-thru, and delivery channels. The market continues to expand due to increasing urbanization, digital ordering adoption, and evolving consumer lifestyles. A key macro driver accelerating market growth is the rapid rise in urban population and changing consumption patterns. According to the United Nations Department of Economic and Social Affairs (UN DESA), nearly 56% of the global population lived in urban areas in 2023, and this figure is expected to reach 68% by 2050.

Cloud based POS system market was valued at $5.7 billion in 2025 and is projected to reach $12.9 billion by 2035, growing at a CAGR of 8.7% during 2026 to 2035. Cloud-based POS systems are increasingly becoming essential across industries such as retail, hospitality, and healthcare, as businesses shift toward digital, scalable, and data-driven transaction platforms. These systems enable real-time transaction processing, inventory tracking, customer engagement, and multi-store management through centralized cloud infrastructure.

Tuberculosis diagnosis and treatment market was valued at $2.4 billion in 2025 and is projected to reach $4.3 billion by 2035, growing at a CAGR of 5.4% during the forecast Period (2026-2035). Regulatory recognition of therapies for difficult-to-treat TB cases fosters market adoption. Health programs and funding for TB eradication facilitate the implementation of enhanced diagnostics and therapies, particularly in high-burden areas, contributing to market growth. For instance, in March 2026, the US Food and Drug Administration (FDA) approved a breakthrough therapy specifically targeting drug?resistant tuberculosis. This all?oral combination regimen was cleared in 2026 after demonstrating substantially higher treatment success rates in Phase III clinical trials compared with traditional therapies for extensively drug?resistant TB (XDR?TB). The therapy received Breakthrough Therapy Designation and Priority Review based on its efficacy and favorable safety profile, marking a significant step forward in addressing forms of TB that have been historically difficult to treat.

Synthetic rubber market was valued at $34.5 billion in 2025 and is projected to reach $54.7 billion by 2035, growing at a CAGR of 4.8% during the forecast Period (2026-2035). Rising demand for sustainable footwear is fueled by the use of recycled tire rubber and plant-based materials, increasing the consumption of synthetic rubber derivatives while promoting environmentally friendly elastomers in the market. For instance, in Feburary 2026, Allbirds introduced a new footwear line featuring INNOVERA, a next?generation bio?designed material made from plant?based proteins and recycled nylon from end?of?life tires. While not solely synthetic rubber, this launch integrates recycled tire rubber components and focuses on sustainable materials innovation in everyday and performance footwear, marking a significant step in reducing reliance on traditional fossil?derived polymers in shoe manufacturing.

Smart syringes market was valued at $1.1 billion in 2025 and is projected to reach $2.5 billion by 2035, growing at a CAGR of 8.7% during the forecast Period (2026-2035). Recent investments in advanced injectable device platforms are enhancing production capacity for smart syringes, which is driving market growth to meet the increasing global demand from hospitals, clinics, and vaccination programs. For instance, in March?2026, ApiJect Systems, a US medical technology company focused on pre?filled injectors and advanced syringe platforms, disclosed total funding of about $111?million across two investment rounds, including backing from major investors such as Royalty?Pharma and Jefferies Financial Group. This capital supports the development of scalable, blow?fill?seal injectable devices, which are relevant to smart syringe manufacturing and distribution infrastructure.

Smart electric meter market was valued at $17.2 billion in 2025 and is projected to reach $35.9 billion by 2035, growing at a CAGR of 7.8% during the forecast Period (2026-2035). Increased investments are driving market growth by integrating smart meters with digital platforms, which enhance analytics, enable remote monitoring, and improve energy distribution efficiency. For instance, in December 2025, Apraava Energy secured $92.1 million in funding from British International Investment and Standard Chartered to enhance smart meter deployment in India, supporting digital grid transformation. The investment will facilitate large-scale installations, reduce losses, improve billing efficiency, and align with India’s national smart metering program under the Revamped Distribution Sector Scheme.

Fertilizers Market is projected to grow from $190.0 billion in 2025 to $275.0 billion by 2035, registering a CAGR of 3.8% during the forecast period (2026–2035). The global fertilizers market is driven by increasing adoption of modern agricultural practices, government support programs and subsidies, rising awareness of soil nutrient deficiencies, and growing use of specialty and micronutrient fertilizers. Government-led initiatives in countries such as India, China, and Brazil promote balanced fertilizer application through schemes focused on soil health management and precision farming. For example, India’s Soil Health Card Scheme provides farmers with soil-specific nutrient recommendations, which helps optimize fertilizer application rates and improve input efficiency. This has resulted in increased demand for customized fertilizers tailored to specific soil conditions and crop requirements.

Radiation dose management market was valued at $442 million in 2025 and is projected to reach $881.3 million by 2035, growing at a CAGR of 6.2% during the forecast Period (2026-2035). Recent FDA clearance for low-dose radiation therapy for non-oncological conditions signifies an expanded regulatory acceptance, enhancing the scope of radiation dose management solutions and driving market growth. For instance, in March 2026, the US FDA granted 510(k) clearance to Varian (Siemens Healthineers) for its TrueBeam radiotherapy systems to support low-dose radiation therapy (LDRT) in osteoarthritis treatment. This development highlights increasing regulatory support for optimized and controlled radiation dose usage beyond oncology, strengthening the importance of dose management technologies.